Breaking News, Collaborations & Alliances

Center for Breakthrough Medicines Introduces Precision Plasmids Manufacturing

Designed to expedite clinical trial timelines with no wait time to start manufacturing custom plasmids.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Center for Breakthrough Medicines (CBM), a contract development, and manufacturing organization (CDMO), has launched its plasmid manufacturing offering, Precision Plasmids, to provide phase-appropriate plasmid on-demand for any company seeking to accelerate their path to clinic for cell and gene therapies. CBM says it offers no wait times for Precision Plasmids R&D grade for pre- and early clinical phases, and Precision Plasmids Pro grade for toxicology studies, Ph1-2 vector production, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters